
Dr. Stephanie Christenson discusses the association between COPD exacerbations and the increased risks of morbidity and mortality
An infographic exploring the pathophysiology of prurigo nodularis and the role of type 2 inflammation.
In this video soundbite from the ERS-ISIAN 2025 symposium, Dr. Vibeke Backer discusses how Type 2 inflammation drives severe, uncontrolled CRSwNP. It covers key immune cells and biomarkers (e.g., IL-4, IL-5, IL-13, TSLP), global prevalence differences, and the importance of symptom tracking and targeted therapies.

Learn about the disease burden and heterogeneity of chronic obstructive pulmonary disease (COPD).
Professor Matthias Augustin details the various clinical manifestations of prurigo nodularis, illustrating how different lesion types can present concurrently in patients.
Professor Matthias Augustin highlights the role of type 2 inflammation in chronic itch across distinct pruritic skin diseases and the cumulative burden of chronic itch and skin lesions in PN.

Dr. Hawkes highlights how Chronic Urticaria is a mast cell centric disease with moderate levels of spontaneous remission in patients.

Dr Hawkes provides an overview of the distinctive characteristics of wheals and angioedema in clinical manifestation

Learn how partnering with patients and considering the clinical relevance of symptom improvements can improve patient quality of life

Learn how loss of smell in CRSwNP is a key symptom for both patients and providers.
This infographic explores the emerging concepts of disease activity, disease stability, and disease control in COPD.
Join Professors Matthias Augustin and Sarina Elmariah for an engaging ADVENT symposium as they explore the pivotal role of type 2 inflammation in prurigo nodularis and chronic itch.